1.
AtehortĂșa S, Senior JM, Castro P, Ceballos M, Saldarriaga C, Giraldo N, et al. Cost-utility analysis of an implantable cardioverterdefibrillator for the treatment of patients with ischemic or non-ischemic New York Heart Association class II or III heart failure in Colombia. biomedica [Internet]. 2019 Sep. 1 [cited 2024 Jul. 3];39(3):502-1. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/4235